Delivery Order SPE2DB25D3202-SPE2DB25FTAYV
- Not listed
- The Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $26,189.68 firm fixed price delivery order contract to provide TABRECTA 200 MG TABLET UU 56S pharmaceuticals. The contract has a completion date of March 25, 2024 and was awarded on March 4, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00 through...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of TABRECTA 200 mg tablets in quantities of 56 units. This is a firm fixed-price contract with a ceiling value of $14.4K and an ultimate completion date of September 10, 2025. The contract carries no set-aside designation and represents a competitive award through open procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform...
- The Defense Logistics Agency awarded a $14,428.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Tabrecta 200 mg tablets (56-count units). This is a non-set-aside competitive award with an ultimate completion date of August 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this order at its corporate office location. The delivery order represents a typical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,428.06 firm-fixed-price delivery order is for TABRECTA 200 MG Tablets. The contract has an ultimate completion date of February 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of Tabrecta 200 mg tablets (56-count units) under a firm fixed-price contract with a ceiling value of $15,204.96 and an ultimate completion date of January 23, 2026. This non-set-aside award represents a competitive procurement for pharmaceutical products to support federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $15,204.96 to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Tabrecta 200 mg tablets (56-count units). This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of December 16, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded a $14,428.06 delivery order to AmerisourceBergen Drug Corp for Tabrecta 200 mg tablets (56-tablet units) with a completion date of September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA. The company, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,214.03 contract is for the delivery of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product, with a performance period through June 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a $14.4K delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Tabrecta 200 mg tablets (56-count units). This non-set-aside, firm fixed-price contract is scheduled for completion by October 3, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- This federal contract award, with a value of $14,428.06, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product. The contract has an ultimate completion date of January 30, 2025, and uses a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC)...
- SPE2DB25D3202Indefinite Delivery Contract
- SPE2DB25D3202-SPE2DB25FTAYVDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for TABRECTA 200 mg tablets (56-count units) valued at $7,214.03 under a firm fixed-price contract type. The award, issued on July 18, 2025, with an ultimate completion date of August 8, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems, performing the work at its corporate office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Through this strategic contract vehicle, AmerisourceBergen Drug Corp serves multiple federal healthcare customers including the Defense Health Agency and U.S. Coast Guard, providing flexibility in fulfilling diverse federal medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 7/18/25 |